LLY vs REGN: Stock Research Comparison
A side-by-side look at Eli Lilly and Company (LLY) and Regeneron Pharmaceuticals (REGN) on factual company data. Valarn runs the same multi-agent AI research — fundamentals, news, sentiment, valuation, and a structured bull-vs-bear debate — on each. Educational research, not advice.
| Sector | Healthcare | Healthcare |
|---|---|---|
| Industry | Drug Manufacturers - General | Biotechnology |
| Headquarters | Indianapolis, IN, US | Tarrytown, NY, US |
| Exchange | NYSE | NASDAQ |
| IPO year | 1972 | 1991 |
| Employees | 50,000 | 15,410 |
This comparison uses factual company reference data and is for informational and educational purposes only. It is not investment advice, and not a recommendation to buy, sell, or hold any security. Always do your own due diligence.